SEC Form 4 · accession 0001445064-15-000147
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Trudeau
Officer — President & CEO · Director
Period of report
Nov 30, 2015
Accepted (ET)
Dec 2, 2015 · 9:02 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nov 30, 2015 | P | 1,350 | $65.885 | A | 167,526 | D |
Table II — derivative securities
No Table II lines on this filing.